Notably, both SphK isoenzymes were equally responsible for insulin-induced cell cycle progression and the proliferation of MCF-7 breast cancer cells, although SphK1 and SphK2 had different roles in mediating insulin-induced ERK1/2 and Akt activation [102]. The gene discussed is INS; the disease is breast carcinoma.